AAREN: Continuous Glucose Monitoring Profile Description Under Alpelisib treAtment in Patients With Advanced bREast Cancer
Latest Information Update: 07 Mar 2024
At a glance
- Drugs Alpelisib (Primary) ; Fulvestrant (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- Acronyms AAREN
- 11 Nov 2021 New trial record